Desmoid

13 registered clinical trials studyying Desmoid — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	PRISM for Depression and Anxiety in Young Adults With Cancer NCT06502483	Dana-Farber Cancer Institute	N/A
Not Yet Recruiting	A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patien NCT06355921	Blokhin's Russian Cancer Research Center	N/A
Recruiting	Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoa NCT06224283	Istituto Ortopedico Rizzoli	—
Recruiting	Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis NCT06268457	Istituto Ortopedico Rizzoli	—
Recruiting	FOG-001 in Locally Advanced or Metastatic Solid Tumors NCT05919264	Parabilis Medicines, Inc.	Phase 1 / Phase 2
Unknown	Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor NCT05490667	Henan Cancer Hospital	N/A
Unknown	Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy Histo NCT05284305	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	—
Recruiting	Cryotherapy in the Treatment of Desmoid Tumors NCT05091255	Istituto Ortopedico Rizzoli	N/A
Active Not Recruiting	A Study of AL102 in Patients With Progressing Desmoid Tumors NCT04871282	Immunome, Inc.	Phase 2 / Phase 3
Completed	Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis NCT03966742	Rabin Medical Center	Phase 2
Completed	Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Ro NCT03275818	Grupo Espanol de Investigacion en Sarcomas	Phase 2
Withdrawn	HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Soli NCT02557854	Theodore Laetsch	Phase 1
Completed	Endoxifen in Adults With Hormone Receptor Positive Solid Tumors NCT01273168	National Cancer Institute (NCI)	Phase 1